NHIA_AnnualConference_24_White

Executive Preconference

Is Oncology the Next Frontier for Home Infusion?

Despite extensive experience in administering a wide range of immune therapies in the home setting, cancer-related treatments have been slower to migrate to the home setting. Hear from clinicians and payors who have developed programs to address the unique needs of cancer patients receiving treatment at home.
Despite extensive experience in administering a wide range of immune therapies in the home setting, cancer-related treatments have been slower to migrate to the home setting. Hear from clinicians and payors who have developed programs to address the unique needs of cancer patients receiving treatment at home.

Learning Objectives

  • Identify the driving forces behind the increase in oncology and immunotherapy in the home setting.
  • Review the most common therapies provided in the home setting.
  • Identify aspects from payors regarding oncology in the home.
  • Speaker(s)

    Nancy Kramer BSN, RN, CRNI, FNHIA
    Vice President Clinical Services
    Optum Infusion Services

    Joseph Owen PharmD
    Executive Director, Specialty Operations, Coram CVS Specialty

    Burt Zweignehaft PhD, DLitt
    Managing Partner
    Upstream Partners

    Speaker
    Speaker
    Speaker

    Share:

    Registration for the Executive Preconference Required